Praxis Precision Medicines has won Food and Drug Administration breakthrough-therapy designation for its ulixacaltamide drug candidate for the treatment of patients with essential tremor.

In December 2025, Praxis announced the successful completion of its pre-NDA meeting with the FDA, including the receipt of written feedback and an in-person meeting. The Company has aligned with the ...

In the past, Rob was romantically linked with fellow cast member Daniel Brocklebank, who portrays vicar Billy Mayhew on the ...

The question of whether invasive or noninvasive methods provide the best possible outcomes for patients with ...

Essential tremor (ET) is a common movement disorder affecting about 2% of the American population, and more than 20% of those over 90 years old. Despite its prevalence and decades of study, ...

Parkinson’s disease (PD) is one of the fastest-growing neurological disorders in the world, with around 60,000 Americans receiving a Parkinson’s diagnosis each year and nearly 1 million Americans ...

Progressive’s auto insurance division recently announced that it will begin paying back about $950 million in excess profits taken in over the past three years from its policyholders in Florida. The ...

It's been a long time coming, but Battlefield 6's new standalone battle royale, Battlefield Redsec, is Battlefield Studios' second stab at the genre after Battlefield 5's lacklustre Firestorm in 2019.

Botox is a brand-name injectable botulinum toxin that can be prescribed off-label for essential tremor. With off-label use, doctors prescribe a drug for a different condition than what it’s approved ...

HONOLULU — New imaging data may explain how transcutaneous afferent patterned stimulation (TAPS), a noninvasive, wearable therapy, works in patients with essential tremor (ET). In a small study that ...

Praxis Precision Medicines surged after positive Essential3 data for ulixacaltamide in essential tremor, but tolerability issues limit enthusiasm. Ulixacaltamide demonstrated functional benefit, but ...